Development of a dual fluorogenic and chromogenic dipeptidyl peptidase IV substrate

被引:36
作者
Ho, NH [1 ]
Weissleder, R [1 ]
Tung, CH [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Mol Imaging Res, Charlestown, MA 02129 USA
关键词
dipeptidyl peptidases DPP-IV; fluorogenic; chromogenic; fluorescent assay;
D O I
10.1016/j.bmcl.2006.02.045
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new far-red dual fluorogenic and chromogenic substrate, 5-glycylprolylglycylprolyl-9-di-3-sulfonyl-propylaminobenza[a]phenoxazonium perchlorate (GPGP-2SBPO), wits developed for dipeptidyl peptidase IV (DPP-IV) sensing. The glycylprolylglycylprolyl tetrapeptide was chosen as the recognition sequence due to its stability under physiological conditions. In contrast, the truncated substrate, GP-2SBPO, containing only a glycylprolyl peptide, is unstable. Proteolysis of GPGP-2SBPO was assayed by monitoring the absorbance and fluorescence signals from the released fluorochrome, 2SBPO, at 625 and 670 nm, respectively. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2599 / 2602
页数:4
相关论文
共 12 条
  • [1] Fluorogenic substrate [Ala-Pro]2-cresyl violet but not Ala-Pro-rhodamine 110 is cleaved specifically by DPPIV activity:: A study in living Jurkat cells and CD26/DPPIV-transfected Jurkat cells
    Boonacker, E
    Elferink, S
    Bardi, A
    Fleischer, B
    van Noorden, CJF
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2003, 51 (07) : 959 - 968
  • [2] Development of novel assays for proteolytic enzymes using rhodarnine-based fluorogenic substrates
    Grant, SK
    Sklar, JG
    Cummings, RT
    [J]. JOURNAL OF BIOMOLECULAR SCREENING, 2002, 7 (06) : 531 - 540
  • [3] Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 rats and mice
    Hartmann, B
    Thulesen, J
    Kissow, H
    Thulesen, S
    Orskov, C
    Ropke, C
    Poulsen, SS
    Holst, JJ
    [J]. ENDOCRINOLOGY, 2000, 141 (11) : 4013 - 4020
  • [4] Development of water-soluble far-red fluorogenic dyes for enzyme sensing
    Ho, NH
    Weissleder, R
    Tung, CS
    [J]. TETRAHEDRON, 2006, 62 (04) : 578 - 585
  • [5] Inhibition of the activity of dipeptidyl peptidase IV as a treatment for type 2 diabetes
    Holst, JJ
    Deacon, CF
    [J]. DIABETES, 1998, 47 (11) : 1663 - 1670
  • [6] A NEW DIPEPTIDE NAPHTHYLAMIDASE HYDROLYZING GLYCYL-PROLYL-BETA-NAPHTHYLAMIDE
    HOPSUHAV.VK
    GLENNER, GG
    [J]. HISTOCHEMIE, 1966, 7 (03): : 197 - &
  • [7] KINETICS AND MECHANISM OF THE FACILE CYCLIZATION OF HISTIDYL-PROLINEAMIDE TO CYCLO (HIS-PRO) IN AQUEOUS-SOLUTION AND THE COMPETITIVE INFLUENCE OF HUMAN PLASMA
    MOSS, J
    BUNDGAARD, H
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1990, 42 (01) : 7 - 12
  • [8] NEW CHROMOGENIC SUBSTRATES FOR X-PROLYL DIPEPTIDYL-AMINOPEPTIDASE
    NAGATSU, T
    HINO, M
    FUYAMADA, H
    HAYAKAWA, T
    SAKAKIBARA, S
    NAKAGAWA, Y
    TAKEMOTO, T
    [J]. ANALYTICAL BIOCHEMISTRY, 1976, 74 (02) : 466 - 476
  • [9] Looking and listening to light: the evolution of whole-body photonic imaging
    Ntziachristos, V
    Ripoll, J
    Wang, LHV
    Weissleder, R
    [J]. NATURE BIOTECHNOLOGY, 2005, 23 (03) : 313 - 320
  • [10] Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and β-cell glucose responsiveness in VDF (fa/fa) Zucker rats
    Pospisilik, JA
    Stafford, SG
    Demuth, HU
    Brownsey, R
    Parkhouse, W
    Finegood, DT
    McIntosh, CHS
    Pederson, RA
    [J]. DIABETES, 2002, 51 (04) : 943 - 950